August 23, 2006
Pharmacosmos participates in the ISPD 2006 Congress
(International Society of Peritoneal Dialyses). The ISPD 2006
Congress is held in Hong Kong during the period August 25 - 29,
2006.
For additional information about the ISPD 2006 Congress, please
visit
the International Society of Peritoneal Dialyses Website.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.